• Our Professionals
  • Our Work
  • Our Insights
  • Firm
  • Careers
  • Tools
Finnegan
    • AIA Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • IP FDA Blog
    • Prosecution First Blog
  • Articles
  • IP Updates
  • Podcasts
  • Events
  • Webinars
  • Books

IP FDA Blog

CAFC Affirms That Bringing Infringement Suit Waives Sovereign Immunity to Related Defenses in UFRF v. GE

March 13, 2019

By Katherine T. Leonard

Edited by M. Andrew Holtman, Ph.D.

In University of Florida Research Foundation, Inc. v. General Electric Company, No. 18-1284 (Fed. Cir. Feb. 26, 2019), the CAFC affirmed the district court’s grant of GE’s motion to dismiss UFRF’s infringement allegations. The CAFC held that UFRF waived its Eleventh Amendment sovereign immunity by consenting to federal court jurisdiction when it brought infringement claim against GE. The patent-in-suit described a method and system for “integrat[ing] physiologic data from at least one bedside machine.” Further discussion of the decision can be found on Finnegan’s Federal Circuit IP Blog.

Tags

Food and Drug Administration (FDA), United States Court of Appeals for the Federal Circuit (CAFC), infringement

Related Industries

Life Sciences

Medical Device and Diagnostics

Contacts

Katherine_Leonard
Katherine T. Leonard
Associate
Atlanta, GA
+1 404 653 6556
Email

Copyright © 2019 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Conference

Best Practices in Intellectual Property 2021

June 14-15, 2021

Tel Aviv

Webinar

Patent Law Institute 2021: Critical Issues & Best Practices

April 29-30, 2021

Webinar

Webinar

Patent Law Institute 2021: Critical Issues & Best Practices

April 1-2, 2021

Webinar

Webinar

Patent Year in Review: Key Decisions, Trends, and Strategies

February 25, 2021

Webinar

Conference

Pharma & Biotech Patent Litigation in Europe

February 23-25, 2021

Virtual

Webinar

Building Company Value With Cybersecurity Patents

February 8, 2021

Webinar

Conference

2021 AIPLA Virtual Mid-Winter Institute

February 1-5, 2021

Virtual

Conference

PTAB Bar Association Virtual Thought Leader Summit 2021

January 28, 2021

Virtual

European IP Blog

Subject-Matter Eligibility at the EPO: Life Sciences

January 25, 2021

Due to international data regulations, we’ve recently updated our privacy policy. Click here to read our privacy policy in full.

We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.

  • Privacy
  • Disclaimer
  • EEO Statement

© 2021 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP